Although high ALCAM expression levels have been associated with better outcome and might be predictive for chemotherapy response in breast cancer, the underlying biological mechanism for survival benefit still remains unclear (King et al, 2004; Ihnen et al, 2008). This evidence concerns the gene ALCAM and breast carcinoma.